STEMCELL Technologies Presentation: The CFU Assay: An Established Tool Facilitating the Realization of Next Generation Therapies
Wednesday, May 29, 2024 06:45 PM - 07:00 PM
Exhibit Hall - Theatre A
Global Showcase Presentation
Presenter(s)
- Marta Walasek PhD, Associate Director, Hematopoiesis, STEMCELL Technologies, CANADA
The colony forming unit (CFU) assay is the gold standard for assessing the functional properties of hematopoietic stem and progenitor cells (HSPCs) and remains the only in vitro assay that provides a correlative assessment of HSPC engraftment potential in vivo. To this end, the utility of the CFU assay extends from off-target hemotoxicity screening of compounds and biologics, to quantifying the potency of emerging gene-edited HSPC therapies.
In this talk, we will introduce to you STEMCELL’s comprehensive portfolio of reagents, training and services that have been designed and optimized to enable the standardization, validation and implementation of the CFU assay in a variety of contexts.
SPONSORED BY:
